ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $256,000 | -7.2% | 20,554 | +2.0% | 0.00% | – |
| Q3 2016 | $276,000 | +90.3% | 20,156 | +2.7% | 0.00% | – |
| Q2 2016 | $145,000 | +9.0% | 19,623 | -5.9% | 0.00% | – |
| Q1 2016 | $133,000 | -24.4% | 20,864 | -25.8% | 0.00% | – |
| Q4 2015 | $176,000 | +1.7% | 28,100 | -5.2% | 0.00% | – |
| Q3 2015 | $173,000 | -29.1% | 29,635 | +0.4% | 0.00% | – |
| Q2 2015 | $244,000 | +52.5% | 29,504 | +51.7% | 0.00% | – |
| Q1 2015 | $160,000 | -99.5% | 19,443 | -99.6% | 0.00% | -100.0% |
| Q2 2014 | $32,095,000 | -22.7% | 5,038,427 | -2.2% | 0.01% | -30.0% |
| Q1 2014 | $41,538,000 | -16.5% | 5,153,627 | -29.3% | 0.02% | -16.7% |
| Q4 2013 | $49,728,000 | -66.7% | 7,291,527 | -10.2% | 0.02% | -70.0% |
| Q3 2013 | $149,374,000 | +78.0% | 8,118,210 | +69.2% | 0.08% | +66.7% |
| Q2 2013 | $83,925,000 | – | 4,798,480 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |